The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology Scientific Session ...

Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...

Cryoport stock sees extreme volatility amid growth potential in cell & gene therapy. Read this article to know why I maintain my Sell rating on CYRX.

Future Prospects: The future of the UAE FMCG Logistics market is promising, driven by factors such as the growth of e-commerce, the expanding retail sector, and the UAE’s role as a trade and tourism ...

The principles of lipid management for the prevention of cardiovascular disease (CVD) and how nurses can put these into ...

Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.

Guard Therapeutics announced today that it has reached another key milestone in its ongoing clinical development program. Two-thirds of the approximately 160 planned patients have now been enrolled in ...

With reference to AbbVie's (NYSE:ABBV) and Gubra A/S' (CPSE:GUBRA) joint announcement of March 3, 2025 regarding a license agreement to ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...